Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Phase of Trial: Phase I/II
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Dexamethasone (Primary) ; Ixazomib (Primary) ; Venetoclax (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 02 Jan 2019 Status changed from recruiting to suspended.
- 04 Oct 2018 Status changed from suspended to recruiting.
- 31 Aug 2018 Biomarkers information updated